AVRO - FDA clears AVROBIO's IND for AVR-RD-01 for the treatment of fabry disease April, 29 2019 09:03 AM AVROBIO Inc. The FDA has cleared AVROBIO's (NASDAQ:AVRO) IND application for AVR-RD-01, its gene therapy candidate for the treatment of Fabry disease.More news on: AVROBIO, Inc., Healthcare stocks news, Read more ...